The interpretative problems associated with intraosseous or parosteal pseudoneoplasms may be either radiographic or histological ones. Even radiographically-bland lesions may contain unexpectedly-cellular fibro-osseous or chondro-osseous tissues that are difficult to separate microscopically from those seen in osteosarcoma, chondrosarcoma, chondroblastoma, or giant cell tumor.
This review considers selected osseous lesions that can be mistaken for true neoplasms, with emphasis on pathological differential diagnosis. It has been structured so as overlap minimally with the contents of a prior exposition on this topic in Seminars in Diagnostic Pathology by Hoch & Montag (1) .
Fibrous & Fibro-osseous Proliferations of Bone

Fibrous Dysplasia
The inclusion of fibrous dysplasia in a discussion of pseudoneoplastic proliferations of bone reflects the bias of the authors. It must be acknowledged that neither fibrous dysplasia nor cortical osteofibrous dysplasia has been granted unequivocally nonneoplastic status by consensus.
Fibrous dysplasia (FD) is a fibroproliferative process in one (monostotic) or several (polyostotic) bones. It manifests a haphazardly-distributed osseous component represented by unusual configurations of woven bone (2) (3) (4) (5) . Patients with polyostotic lesions are almost always young children (6, 7) , and many of them also have the pigmentary, endocrine, and soft tissue lesions of Albright disease (5, 6) . Most patients with polyostotic FD exhibit symptoms before the age of 10 years. The incidence of soft tissue and intramuscular myxomas is increased in patients with FD, particularly those with polyostotic disease (8) . Monostotic fibro-osseous proliferations generally affect older children or young adults, although not exclusively. The majority of FD lesions undergo enlargement during normal phases of bone growth, and they become stable in size and appearance when skeletal maturity is attained. Approximately one-third of monostotic FD is seen in the craniofacial bones, where it usually presents as a painless deforming lesion (2) . Long bones--especially the femur and tibia--also account for about one-third of the lesional sites (4) . There, FD may present with pain as a result of intra-or perilesional fracture (290). Patients with polyostotic lesions tend to have pelvic involvement, in addition to lesions in the long bones of the legs (2) .
The radiographic and pathologic features of monostotic and polyostotic FD are similar. Plain-film radiographs reveal a range of ossification that is independent of lesional size. Lightly mineralized lesions also may be cystic, and they may occasionally disrupt the bony cortex with a periosteal reaction. Although a thin sclerotic rim usually separates FD from adjacent bone, some examples appear to blend with the adjacent cortex.
The gross appearance of resected FD is that of a firm fibrous mass with a variable amount of calcified matrix (Fig. 85) . Serous or blood-filled cysts may develop secondarily, and, in approximately 10% of lesions, nodules of mature cartilage may be encountered (9) . Extensive chondroid differentiation has engendered such names as fibrocartilaginous dysplasia (10) and fibrocartilaginous mesenchymoma (11) ; however, the relationship of those lesions to each other and to classical FD is somewhat unclear.
On histological examination, FD manifests irregularly shaped, delicate trabeculae of woven bone, in a moderately cellular fibrous stroma. Mineralized osteoid matrix is typically heterogeneous; osteoblasts are loosely admixed with matrix in amorphous areas and within immature or developing trabeculae (Figure 1 ). In the latter respect, FD may resemble welldifferentiated intraosseous osteosarcoma, a neoplasm whose common location in the proximal tibia may also overlap that of monostotic dysplasia (Figure 2) . The absence of atypia in the osteoblastic population of FD, together with the paucity of osteoblasts within maturing trabeculae distinguishes that pseudoneoplasm from its malignant mimic. In well-developed lesions, osteoblastic "rimming" is largely absent from the trabeculae of FD. When cartilage is present, it shows continuity with ossifying elements.
The fibrous stroma of FD is itself heterogeneous, varying in cellularity and the extent of collagenization. Myxoid changes also may be conspicuous. Stromal cells generally resemble fibroblasts by both light and electron microscopic examination. Cytological atypia, if present at all, is only modest. Occasional multinucleated cells may be present, although aggregates of them are unusual (12) . Such elements may occasionally evoke a resemblance to giant cell reparative granuloma, as discussed later. In areas where a collagenized stroma predominates, FD may resemble metaphyseal fibrous defect or desmoplastic fibroma. In the first of these lesions, cellularity is greater, with more osteoclast-like giant cells and histiocytes. On the other hand, desmoplastic fibroma shows a well-organized, paucicellular collagenous matrix (13) (Figure  3 ). When FD affects the tibia, a challenging differential diagnosis is that of cortical osteofibrous dysplasia, as reviewed below.
Although the risk for malignant transformation of FD (most commonly in the form of osteosarcoma, and, less often, as malignant fibrous histiocytoma, fibrosarcoma, or chondrosarcoma) is very low, that phenomenon is unpredictable (14) (15) (16) ). An antecedent history of radiation therapy for FD-which is ill-advised-pertains to the majority of cases with malignant transformation, but as many as one-third of sarcomas in FD arise spontaneously (14) .
As mentioned above, the form of sporadic bone sarcoma which is particularly likely to be confused with fibrous dysplasia is low-grade central osteosarcoma (LGCO) (17) . Commonly, it is recognized as such only after recurrence of a lesion that has previously been interpreted as FD histologically. Accurate diagnosis is predicated on correlation with results of clinical imaging studies and detailed evaluation of histologic findings. Radiographic features of LGCO are not always diagnostic, but they typically suggest a lesion with greater aggressive potential than that of fibrous dysplasia or other benign proliferations. Such attributes include indistinct circumscription, dense sclerosis, an interrupted periosteal reaction, or cortical infraction by the tumor (18) . Microscopic sections through the center of LGCOs usually demonstrate woven microtrabeculae of bone in a moderately cellular, fibrous stroma (Figure 2) . If sections include the interface of the lesion with normal bone, fibrous tissue within Haversian canals or between mature cancellous trabeculae is a strong sign of malignancy (17) . In the absence of those findings, atypical mitotic activity may lead to the correct diagnosis. Although patients with
LGCO usually are treated with surgery alone, and their prognosis is significantly better than with conventional osteosarcoma, a certain number of patients develop secondary high-grade osteosarcoma (by "dedifferentiation") in the original low-grade tumor, particularly in local recurrences (18) . Dujardin et al. (19) have shown that immunoreactivity for murine double minute type 2 (MDM2) gene product or cyclin-dependent kinase 4 (CDK4) protein, or both, is typical of LGCO. FD and other benign fibroosseous lesions do not express those two markers.
FD has also been mistaken for other benign and malignant bone lesions. They include well-differentiated fibrosarcoma, "solid" aneurysmal bone cyst (SABC), osteoid osteoma, and osteoblastoma (2) (Figure 4) . The first two of those entities lack the "nonsensically"-shaped osteoid trabeculae of FD, and they show a greater degree of cellularity. In addition, SABC contains easily-seen osteoclast-like giant cells. Osteoblastoma and osteoid osteoma demonstrate broadly-interlocking masses of osteoid which are morphologically-dissimilar to those of FD (2) .
Benign Fibro-Osseous Lesions of the Jaws
One group of benign ossifying lesions is peculiar to the jawbones, exclusive of FD, which may also affect that location (21) . The other proliferations are usually designated generically as "benign fibro-osseous lesions" (BFOLs), but are sometimes subdivided into two collections based on their histological characteristics. Those are "ossifying fibroma" (OF) and "cementoossifying fibroma" (COF) (22) (23) (24) (25) (26) (27) . The principal difference between the latter lesions is the nature of the bony matrix in them; OF produces osteoid-like material and bony trabeculae ( Figure 5 ), whereas COF contains matrical material which strongly resembles the cementum of teeth. In some instances, it is arranged concentrically around focal points, yielding psammoma body-like structures ("psammomatous COF") ( Figure 6 ).
All of these lesions may expand the affected bone significantly, but they typically do not breach its cortex. Moreover, they are cytologically-bland, without pathologic mitotic figures. Thus, the conjoint radiographic and histologic features of BFOLs are unlike those of gnathic osteosarcomas (28) (Figure 7) . Moreover, the latter neoplasms are characteristically chondroblastic, whereas cartilaginous tissue is distinctly unusual in BFOLs. Osteoblastomas and osteoid osteomas again differ substantially from BFOLs on imaging studies (2) .
Cortical Osteofibrous Dysplasia, With & Without Adamantinoma
In contrast to FD, the lesion known as cortical osteofibrous dysplasia (COD; Campanacci's disease) is an intracortical or subperiosteal fibro-osseous proliferation that almost exclusively affects the tibia and fibula (29) (30) (31) (32) (33) . It is usually solitary and is not associated with Albright's disease (30) . As in polyostotic FD, children in the first decade of life are typically affected by COD (30, 33) and presentation in early adulthood is unusual (33) . Although it is a deforming lesion of bone, COD is usually asymptomatic (30, 33) . It is not associated with myxomas of soft tissue or muscle. If malignant transformation of COD occurs, it does so by evolution to the development of adamantinoma of long bones.
The radiographic appearance of COD is that of a heterogeneously lucent intracortical mass in the diaphysis of the tibia or fibula (Figure 8) . Lesional expansion appears to preserve the medullary space at the expense of subperiosteal bone (31) . The cortex is occasionally effaced, but the overlying periosteum is preserved. The result is an eccentrically placed mass that produces a bowing deformity in the long axis of the bone. In adults, mature sclerotic lesions of COD may resemble Paget disease (30) . As true of FD, a sclerotic rim may be seen at cortical interfaces, and it generally defines the extent of lesional growth (31) .
The gross appearance of COD depends largely on the degree of ossification it shows (32) . Poorly mineralized lesions comprise soft fibrous tissue, whereas others with extensive ossification may be gritty on cut section. The histologic features of COD superficially resemble those of FD, with irregular trabeculae of variably mineralized bone. An admixture of osteoblasts and osteoid matrix is usually absent. Most bone formation occurs by osteoblasts that are aligned along the peripheral surfaces of trabeculaer in COD. The supporting connective tissue is densely collagenized, with relatively few fibroblasts, although more cellular areas may be apparent in some cases. Hyaline cartilage is uncommon in COD, and when it is present, it generally is an element of a callus in a pathologic fracture. Isolated keratin-reactivity is present in the stromal cells of 33-93% of COD cases, a finding that is not seen in FD (34) (35) (36) .
The microscopic appearance of COD is dichotomous-the lesions either resemble FD (with the same differential diagnostic considerations) or they have a composite histologic image of COD with adamantinoma. The latter relationship requires further elaboration.
Adamantinoma (ADA) is a primary low-grade malignant intraosseous neoplasm that typically affects the tibial diaphysis along its anterior surface (35, (37) (38) (39) (40) (41) (42) . Most ADAs are intracortical, although medullocentric proliferations have also been described. They are usually confined by the periosteum, and those lesions with extraosseous extension are more prone to local recurrence and metastasis. Young adults are usually affected (37) (38) (39) (40) (41) (42) . The singular feature of ADA is its epithelial lineage. The histologic appearance of this tumor encompasses collections of spindle cells; aggregates of basaloid cells; and glandular or tubular structures. The first of those patterns may simulate a fibroblastic or fibrohistiocytic proliferation (38.39) . Irrespective of their cytological appearances, ADAs are immunoreactive for pankeratin and may also express epithelial membrane antigen or carcinoembryonic antigen (34, 35, 40, 43) . In some instances, osteofibrous elements similar to those of COD are clearly admixed with the neoplastic cells of ADA (30, 35, 36, 39, 44, 45) (Figure 9 ). Indeed, it is now generally accepted that the form of COD containing keratin-reactive stromal cells is a precursor to ADA (33, 46) . Therefore, biopsies showing the first of those entities should be reflexively studied immunohistologically for the expression of epithelial determinants. Kashima et al. (47) have shown that podoplanin-immunoreactivity is common to both COD and ADA, further solidifying the interrelationship between those conditions.
Metaphyseal Fibrous Defect (Nonossifying Fibroma)
Nonossifying fibroma is, in our opinion, synonymous with the lesion known as metaphyseal fibrous defect (MFD). As such, it arises in the metaphysis of long bones, particularly the distal femur and the proximal or distal tibia (48) (49) (50) (51) ; involvement of the diaphysis is unusual. Bilateral and multifocal lesions are seen in nearly one-half of patients (48) . A small subset of them has neurofibromatosis (52), with cutaneous cafe-au-lait spots and other congenital abnormalities (53) .
Many patients with MFDs are children, and most are less than 10 years old. MFD is a typically small intracortical lucency that is asymptomatic and often encountered incidentally. Caffey suggested that as many as one-third of prepubescent children have radiologic evidence of one or more MFDs (48) . Many small lesions of this type spontaneously regress, and larger ones tend to be seen in older children or young adults as lytic defects that may cause medullary expansion (51) . MFD may present with pain that is related to pathologic fracture (54) . That lesion arises at or near sites of tendinous insertions, and it may focally erode the outer cortex. The location and the pattern of metaphyseal damage in MFD support musculoskeletal injury as an important etiologic factor (50, 51) .
The radiographic appearance of MFDs is characteristic, and it allows for accurate diagnosis in most cases. Lytic zones in the lesion are sharply demarcated from adjacent cortical bone by a thin sclerotic rim (Figure 10 ). The conjoint clinical and radiological attributes of MFD generally permit confident nonsurgical management of small lesions, as well as conservative surgery for larger and potentially unstable lytic lesions (51, 52) .
It must therefore be acknowledged that most MFDs do not present a great diagnostic challenge for the radiologist or pathologist. However, in cases that present in young adults, the radiographic appearance may be indeterminate. MFD may undergo progressive mineralization and remodeling, resulting in an irregular configuration and density of the lesion (51). After pathologic fracture, medullary hemorrhage, periosteal reaction, or early callus formation in MFD may further mask its characteristic features. Foam cells and hemosiderin deposites are potentially conspicuous in older lesions. Ossification is not a usual element of MFDs; rather, bony trabeculae in them are either reactive in nature or they represent residual cortical elements at the periphery of the lesions (50, 55) . These trabeculae have an "orderly" structure, permitting their distinction from those seen in FD or COD. The stroma of MFD may contain variable amounts of collagen, but dense hyalinization is distinctly uncommon. If it is present, a resemblance to desmoplastic fibroma may obtain, but the storiform configuration spindle cells in MFD effectively excludes that diagnostic alternative. Malignant transformation of MFD probably does not occur, although Kyriakos and Murphy (56) reported an apparently coincidental MFD juxtaposed to an osteosarcoma.
With regard to differential diagnosis, it is probably not possible to separate fibrous histiocytoma (FH) of bone from MFD on histologic grounds alone (56) (57) (58) . Nevertheless, FHs do not show an exclusive localization in the metaphysis of long bones, as does MFD. Involvement of bones by FHs is often diaphyseal, with potential extension to the metaphysis or epiphysis; moreover, they most often affect axial skeletal sites, unlike MFDs. FH of bone also continues to be seen throughout adulthood, and, in further contrast to MFD, it may be painful even in the absence of fracture. Finally, osseous FH may recur after curettage or it may sometimes behave in a locally aggressive fashion (57) . In general, the differential diagnosis between MFD and FH is only problematic in metaphyseal lesions in long bones in patients over the age of 25 years. Arbitrary bias on the diagnostic side of FH may be appropriate in those cases, to assure proper surgical management.
Fibroinflammatory & Reactive-Reparative Lesions
Giant Cell Reparative Granuloma
Giant cell reparative granuloma (GCRG) is a clinically-distinctive intraosseous proliferation that contains numerous osteoclast-like giant cells. It is most often encountered in the mandible or, less commonly, the maxilla (60-63) (Figure 11 ). Cranial bones are only rarely affected (63, 64) . Multiple lesions in the mandible, particularly if they are symmetric and bilateral, may present the image of the heritable disease known as "cherubism" (65) . Apart from exceptional cases of true giant cell tumors, some of which are associated with Paget disease of bone (66) (67) (68) , few other lesions enter the differential diagnosis of GCRG. However, it has also been described in distal appendicular skeletal sites, most notably the phalanges or metatarsal and metacarpal bones (69) (70) (71) (72) (73) (74) (Figure 12 ). Most GCRGs are solitary, and multifocal examples tend to be those in the distal extremities (68) .
Although GCRGs in the hands and feet are seen over a wide age range, most patients are in the second to fourth decades of life, and most of them are over the age of 30 years at diagnosis (73) . Those figures overlap with the peak incidence of true giant cell tumor (GCT), although, on average, patients with that true neoplasm are older (2) . The symptoms of swelling and pain are variable in cases of GCRG, and prior trauma does not appear to be a common element in the clinical presentation (70, 74) .
The radiographic appearance of GCRG is that of an expansile but well-delimited lytic lesion beneath an attenuated but intact cortex. Although most of the lesions are radiolucent, internal trabeculae of mineralized tissue are sometimes evident. Involvement of periosteal or extraosseous soft tissue by GCRG is distinctly uncommon (64, 72) . There is no perilesional sclerosis, and periosteal reactions are generally absent (70, 73) . With the exception of rare epiphyseal GCRGs described by Lorenzo and Dorfman (71), distal lesions of this type are almost exclusively centered in the metaphysis or diaphysis of the affected bone. This localization provides a useful point of contrast with typical examples of GCT, which is an epiphyseal tumor (2).
Macroscopically, GCRG has no singular characteristics. Heterogeneously-colored soft tissue predominates (69, 71) , but areas of cystic degeneration may also be present (73) . Histologically, the lesion contains irregularly-distributed multinucleated osteoclast-like giant cells in a supporting fibrous stroma that varies in cellularity. The background cell population comprises fusiform or ovoid fibroblasts, and paucicellular hyalinized areas may be appreciated as well (Figures 11 & 12) . Reactive bony trabeculae and islands of osteoid are interspersed in the fibroblastic and giant cell proliferation, but most mature osseous elements are encountered at the lesional periphery. In areas where they are inconspicuous, the lesion may resemble MFD histologically (71, 73) . Most bony trabeculae in giant cell reparative granuloma are mantled with osteoblasts, but if they are lacking, an image results which can simulate that of FD (71) . The giant cells in GCRG are principally centered on areas of hemorrhage or clustered in aggregates (Fig. 113) . Cystic vascular spaces also may arise secondarily in this lesion, producing an appearance like that of aneurysmal bone cyst (ABC). Indeed, it is likely that GCRG and ABC belong to the same broad family of reparative-reactive bone lesions.
There are no particular immunohistochemical or electron microscopic features that allow for a unique characterization of GCRG. Moreover, its biochemical and ultrastructural phenotype overlaps in large part with that of GCT (75) .
As implied in the foregoing discussion, the most important differential diagnosis for GCRG is that of GCT. The lack of epiphyseal involvement by GCRG is a helpful feature. Furthermore, the fibroblastic nature of background elements and the irregular distribution of giant cells in that lesion separates it from the typical microscopic image in GCT. That tumor has a more uniformly ovoid stromal-cell population, the nuclei in which share a morphological likeness to those of the giant cells (2) (Figure 13 ). In GCRG, the stromal-cell nuclei are elongated with tapered ends (2). The accurate diagnosis of GCT has considerable importance because of its tendency for recurrence, and its rare ability to undergo sarcomatous transformation or metastasize.
Brown Tumor of Hyperparathyroidism
The giant cell lesion of hyperparathyroidism (GCLH; "brown tumor") is basically indistinguishable from giant cell reparative granuloma histologically, but the former of those lesions invariably arises in patients with clinical or laboratory evidence of hyperparathyroidism. That condition is reflected by increased serum levels of calcium, phosphate, alkaline phosphatase, and parathyroid hormone (76) (77) (78) . The absence of such laboratory changes is an obligate criterion for the diagnosis of GCRG. The one point of morphological difference between GCLH and GCRG is that brown tumors are also associated with microscopic evidence of active bone resorption, with numerous osteoclasts mantling bone trabeculae (Figure 14) .
Nevertheless, that observation requires a sampling of adjacent non-lesional bone.
Brown tumors are also accompanied by radiographic evidence of diffuse osteopenia in plain-film radiographs of the hands and feet, often with erosion of the tufts of the phalanges. The calvarium is similarly affected, producing a "salt and pepper" skull (76, 77) . Favored anatomic locations for the tumefactive lesions include the vertebral bodies, distal clavicle, symphysis pubis, and lamina dura of the jawbones (77) . In rare instances, several bones harbor brown tumors simultaneously, and they may thus imitate the radiographic appearance of osseous metastases (77, 78) .
The metaphyseal location of aneurysmal bone cyst (ABC), and the tendency for giant cells to aggregate near cystic or hemorrhagic foci, make the histologic appearance of that lesion difficult to distinguish from giant cell reparative granulomas and brown tumors as well, particularly when solid foci predominate (79) (80) (81) . The potential presence of secondary cystic change in GCRG and GCLH further complicates this differential diagnosis. Convention dictates that the presence of lesions resembling ABC in the bones of hands and feet should be interpreted as representing GCRG or GCLH in those locations (75) .
Synovial Chondrometaplasia-Synovial Chondromatosis
As a primary metaplasia, synovial chondromatosis (SC) is distinctive among pseudoneoplasms in skeletal and articular tissues. Usually monoarticular in nature, synovial chondromatosis arises as a multinodular process in synovium, bursa, or tendon sheaths in or around the large joints, particularly the knee. The nodules secondarily detach themselves, becoming free in the synovial spaces as loose bodies (82) (83) (84) (85) (86) (87) (88) . Extraarticular lesions can also occur (89) .
The radiographic appearance of SC in both intra-and extraarticular sites is variable, although most lesions are characteristically radiolucent. Varying degrees of mineralization reflect a tendency for the cartilaginous nodules to calcify or undergo ossification (82-84).
Histologically, SC is represented principally by mature hyaline cartilage. However, constituent nuclei may be hyperchromatic with large irregular shapes, and multinucleated chondrocytes might be present (Figure 15 ). Cellular areas may also exhibit varying degrees of mitotic activity, but the overall architectural and cytological atypia that typifies chondrosarcoma is absent. Separation of SC from enchondroma is not problematic because of the clearlyintraosseous location of the latter tumor, but a distinction of metaplastic cartilage from soft part chondromas might not be possible in the circumstance when chondromatosis occurs in or near synovial tissues. This situation is further complicated by an increased incidence of true cartilaginous neoplasms of the soft tissue in patients with SC (90, 91) . Nevertheless, the benign clinical behavior of soft tissue chondromas makes this distinction unimportant pragmatically.
The pattern of ossification in SC resembles normal enchondral ossification; osteoblastic atypia is not seen. The nodular growth of SC, detached from bone, likewise precludes the misdiagnosis of osteochondroma (92) . Although malignant transformation to chondrosarcoma has occurred in rare, anecdotal instances of SC (93) (94) (95) (96) , local persistence of chondrometaplasia is a more common problem (86) . Typical chondrosarcoma is an intraosseous process ( Figure  16 ), differing from the clinicopathologic profile of SC.
Aneurysmal Bone Cyst
Aneurysmal bone cysts (ABCs) are generally encountered in the metaphysis of long bones or in vertebrae, although virtually any other bone in the body may occasionally harbor them (80, 81) . Most aneurysmal bone cysts affect young individuals, usually before the third decade of life.
The lesions are often painful, and they may be symptomatic for only relatively short periods of time before clinical diagnosis (80, 81, (97) (98) (99) (100) .
In long bones, ABCs most often arise in the distal femur and proximal tibia (80, 97, 98, 100) . In vertebrae, they often affect the posterior arch and spinous processes--with secondary extension into the vertebral body--and have a peculiar tendency to involve adjacent bones (100) . Lesions in small bones of the distal extremities have also been described (101) . The majority arises in cortical or medullary bone; fewer than 10% primarily are seen in subperiosteal sites (102, 103) .
The radiographic appearance of ABC evolves over the life of the lesion (102) (103) (104) . Initially, it is small, often eccentrically-placed in the affected bone, and does not expand the cortex. In this "incipient" phase, the borders of the lesion are indistinct and may exhibit a permeative pattern of growth into adjacent cortex or medulla. In the so-called "growth" phase of ABC, rapid enlargement is associated with bony expansion, osteolysis, and cortical destruction. There may be sufficient periosteal injury to cause formation of a "Codman's triangle" radiographically, as seen in osteosarcoma. In rapidly-enlarging lesions, portions of the cortex may appear to be lost entirely. However, the medullary margins of the lesion remain distinct, a feature that may help to distinguish proliferative ABC from osteosarcoma or other intraosseous malignancies. Following rapid expansion, ABC assumes a more stable phase wherein the classic radiographic appearance emerges of an expanded, lytic, trabeculated, metaphyseal lesion with distinct perilesional sclerosis. With time, the trabeculae may progressively ossify (100).
The gross appearance of intact ABC is not often seen in surgical specimens, because only curetted fragments are submitted to the pathology laboratory. In larger pieces of tissue, or when the entire lesion is available for examination, the most conspicuous feature is a catacomb of cavernous or aneurysmal blood-filled spaces (80, 99) . The prominence and thickness of more solid trabeculae within the lesion depends on the stage of incisional growth in which the specimen has been obtained. In older lesions, coarse bony trabeculae may be prominent. The lesion, apart from its aneurysmal characteristics, may also be conspicuously cystic with serous and serosanguinous fluid filling irregularly sized spaces. Predominantly or exclusively solid variants of ABC are uncommon (105, 106) .
The histologic features of aneurysmal bone cyst are variable from case to case, but they encompass a fairly consistent range of features that allow for confident diagnosis in the majority of cases (80, 81, (97) (98) (99) . Cystic or aneurysmal blood-filled spaces, from which the name of the lesion is derived, are characteristic of all but the solid variant lesions (Figure 17) . Neither careful histologic, ultrastructural, nor immunohistochemical analyses have identified an endothelial lining on the surface of these spaces (100, 107, 108) , although the presence of arteriovenous malformations within resected aneurysmal bone cysts suggests that vascular trauma may be an important factor in their development (97, 109) . The aneurysmal spaces are separated by fibrous septa of varying thicknesses and configurations that are relatively cellular, populated by fibroblasts and an admixture of chondroid or osteoid matrix, multinucleated giant cells, mononuclear histiocytoid cells, and a bland lymphoplasmocytic inflammatory infiltrate. Giant cells may congregate beneath the lining of the blood-filled spaces but do not actually constitute an element of the lining or reside within the space. In many areas, the admixture of cellular elements may resemble those seen in giant cell reparative granuloma or giant cell tumor.
Ossification within the lesion may be conspicuous in older lesions. Bone formation either arises as a mineralization of osteoid in a manner very similar to that seen in fibrous dysplasia or develops together with a rim of primitive chondromyxoid matrix (20, 100) . The latter, regarded by some as characteristic of ABC (81), often occupies large areas in the septa that are independent of osteoid and may line the blood-filled spaces. This characteristic matrix often calcifies in a focal, heterogeneous pattern that clearly distinguishes ABC from chondroblastoma (2) . Osteoid is often conspicuous in calcifying ABCs, and may assume a linear, trabeculaer, or lace-like configuration. The matrix is usually associated with mitotically active but cytologically bland mononuclear cells. At the periphery of the lesion, aneurysmal spaces may interdigitate with cortical bone; in lesions that have eroded through the cortex, the characteristic histologic components of ABC may also be present in extraperiosteal soft tissue (100).
In cases of "solid" ABC (105, 106) , all of the features evident in the septa of typical examples are represented, including the distinctive chondroid matrix. But for lack of aneurysmal spaces, the juxtaposition of these elements bears a strong resemblance to the image of GCRG. Because most of the solid lesions reported by Sanerkin & colleagues (110) also contained small foci in which ectatic blood-filled spaces were present, the diagnosis of aneurysmal bone cyst may have been justified in that series of cases. However, it is accepted that many lesions histologically characteristic of ABC are associated with, or arise as a secondary phenomenon in, several intraosseous lesions (104, (110) (111) (112) . These include GCRG and GCT, among others. Although the anatomical distributions of ABC and GCRG do not overlap to any great extent, the microscopic similarities between those lesions suggest a common histogenesis (106) . This relationship also serves to emphasize the fact that the diagnosis of primary ABC requires that another definable lesion of bone must be excluded first. The morphological elements of ABC may be superficially recapitulated in selected osteosarcomas, osteoblastomas, GCTs, chondroblastomas, and chondromyxoid fibromas. So common is the association between aneurysmal changes and GCRG-like foci that some authors have suggested that all ABCs are secondary phenomena, wherein the original lesion is "overrun" and no longer identifiable (112) . However, we do not subscribe to that view.
Apart from the separation of "solid" ABC from GCRG in appendicular sites, and the exclusion of other primary underlying lesions, the differential diagnosis of ABC is based on the nature and distribution of its osseous elements. Even though ABC may be somewhat destructive in some cases, and it may contain mineralizing osteoid and mitotically-active cells, the clinicopathologic confusion between ABC and telangiectatic osteosarcoma (TOS) (113) (114) (115) (116) (117) should be an uncommon event. Nevertheless, that is the most serious diagnostic problem encountered in this context. In TOS, compact irregular trabeculae of osteoid are associated-with cytologicallyanaplastic osteoblasts that contain atypical mitotic figures (115) (Figure 18 ). In addition, that tumor is virtually always overtly aggressive, with marked expansion of the affected bone, destruction of its cortex, and common extraosseous extension into adjacent soft tissue (114) .
Although large, destructive ABCs require surgical resection, curettage or excision with bone grafting is the usual therapy for this lesion (100, 101) . Recurrence of true ABC may be see within 6-24 months if subtotal removal is effected (100, 102, 109) , and ABC-like changes may also be seen in recrudescent true neoplasms, as mentioned above (97) . Malignant transformation in primary ABC is extraordinarily rare, and is usually associated with a prior history of radiation therapy (100). Kyriakos & Hardy also have reported one case in which no such previous treatment was given (118) .
Tumefactive Chronic Osteomyelitis
In both its acute and chronic forms, osteomyelitis (OM) typically presents few clinical diagnostic problems. Patients with that condition characteristically have had a known bacterial infection previously-either a localized or a systemic one-and they are febrile with malaise, leukocytosis, and discomfort in the affected bone or bones (119, 120) .
Nonetheless, occasional examples of chronic OM lack those features altogether, and present themselves with vague pain at a single infected site. Radiographic findings in such circumstances may be represented by a relatively well-demarcated, lucent, or mixed-density tumefactive lesion in the diaphysis or metaphysis (121) (122) (123) (124) (125) (126) (127) . Alternatively, diffuse expansion of the bone may be observed, sometimes with periosteal changes that resemble those of "Codman's triangle." In the first of those settings, osteoid osteoma may be suspected diagnostically (128) ( Figures 19 & 20) ; in the second, Ewing sarcoma or lymphoma is commonly considered interpretatively (121) (122) (123) (124) (125) (126) (127) (129) (130) (131) (132) (133) (Figures 21 & 22 ).
Yet another variant of chronic OM has a similar name, but it is noninfectious in nature and does not respond to antibiotics. That condition is called chronic recurrent multifocal osteomyelitis (CRMO), which has a preference for female patients in late childhood and adolescence (134) (135) (136) . The onset of CRMO is typified by malaise and bone pain at the lesional sites. Early on, that disorder may be unifocal, but it characteristically progresses to yield multifocal metaphyseal lesions. Differential diagnosis thus may include a metastatic solid tumor, a hematolymphoid malignancy, and Langerhans-cell histiocytosis. Some affected individuals also have cutaneous palmoplantar pustulosis. Once the clinicopathologic diagnosis of CRMO is established, treatment with nonsteroidal anti-inflammatory agents is recommended, rather than the use of antibiotics.
Regardless of whether the patient in question has postinfectious chronic OM or CRMO, histologic findings in biopsies or curettage specimens are comparable (121, 122, 136) . They include an infiltrate of lymphocytes, plasma cells, and histiocytes in the bony medulla, with inflammatory involvement of osseous trabeculae and the presence of devitalized bone. Secondary cortical osteogenesis may be evident as well, but a "nidus" is not seen as in cases of osteoid osteoma. Histochemical stains for microorganisms are virtually always negative in cases of chronic OM.
If the latter diagnosis is being considered microscopically, the size and nature of the surgical sample must be considered. Curettage specimens comprising a good volume of tissue are the most reliable pathologic substrates. On the other hand, changes resembling those of chronic OM may be seen adjacent to other bony lesions-including neoplasms-and, therefore, needle biopsy specimens may be non-representative and are not as dispositive.
The radiological and microscopic features of diagnostic alternatives such as Ewing sarcoma and lymphoma are discussed elsewhere in this issue of Seminars. In selected circumstances, either of those tumors could be confused with chronic OM radiographically and histologically.
A well-recognized complication of chronic OM is the formation of draining osteocutaneous fistulas. Rarely, those lesions may, over time, give rise to secondary squamous cell carcinomas of the skin, which may grow downward into the underlying bone (137) .
Proliferative & Tumefactive Paget Disease of Bone
Paget disease of bone (PDB), also known as osteodystrophia deformans, is a metabolic condition that may have an etiological association with prior viral infections (138, 139) . It typically progresses sequentially through three phases of development, featuring osteoclastic activity; mixed osteoclasis & osteoblastosis; and osteoblastic proliferation. A single focus of disease may be present, but it is more typical to see polyostotic PDB. The skull, vertebrae, and long bones are primarily affected, and pain at the lesional sites is common. Various biochemical abnormalities are also present in PDB, including elevation of the serum level of alkaline phosphatase in the face of normocalcemia, and elevated urinary levels of pyridinoline and hydroxyproline. The latter moieties are indicators of increased bony turnover (139).
Histologically, one initially observes an increase in bone resorption in PDB, associated with the presence of numerous large osteoclasts. This osteolytic phase is followed by compensatory bone formation with induction of osteoblastic activity and accelerated deposition of lamellar trabecular bone with a disorganized pattern (76, 138, 139) . It is often called "mosaic," in contrast to the normal linear lamellar image. Marrow spaces are replaced by fibrous tissue and a proliferation of blood vessels, causing the bone to become hypervascular. At the end-stage of PDB, only densely sclerotic and mosaic lamellar bone is apparent, and gross deformations are characteristic (138) .
In approximately 1% of cases, a primary osseous malignancy makes its appearance in PDB (139) ( Figure 23 ). Osteosarcoma is most often seen, but high-grade fibrosarcoma or pleomorphic sarcoma is evident in approximately 10% of transformed cases (67, (140) (141) (142) . Sarcomatous evolution in Paget disease is typified by increased pain in the affected bone, and an overtlydestructive lesion that is superimposed on the usual image of PDB in plain film radiographs (141) .
Rarely, the proliferative phase of Paget disease may itself produce a mass, the clinical and radiological appearances of which are strongly suggestive of a sarcoma. When such lesions are subjected to biopsy or excision, they show only the typical image of PDB histologically, with no evidence of malignancy (143) (144) (145) (146) (Figure 24 ). Nevertheless, a report by Franchi et al. (147) complicates this situation. Those authors documented 2 cases in which low-grade osteosarcomas produced trabecular bone with a pagetic image, imitating the pattern of osteogenesis in PDB. If interpretative doubt exists, one may utilize immunostains for MDM2 gene product-as discussed earlier-in this context. PDB is MDM2-negative, whereas osteosarcomas typically express that marker (19) . Pseudotumor formation in Paget disease does not alter the prognosis of that condition, but it may require additional surgical intervention to alleviate pain or correct a gross deformity.
Polyvinylpyrrolidone Storage Disease
Polyvinylpyrrolidone (PVP) is a polymer that has been used in the past as a plasma expander in transfusion medicine; it also has been employed as a food additive, a carrier for certain injectable medications, and a constituent of some hair-care products (148) . When PVP enters the circulation, it cannot be excreted in the urine and is potentially deposited in several tissue sites. These include the bones, skin, liver, spleen, and lymph nodes (149) . In the first of those locations, PVP storage disease may produce single or multiple lytic osseous defects that simulate the appearance of a primary or metatatic neoplasm radiographically.
Microscopically, one sees sheets of large epithelioid cells with vacuolated, sometimes-bluish cytoplasm in this condition. Their nuclei are often eccentric, and they are bland morphologically (Figure 25 ) (150) (151) (152) (153) . The histological differential diagnosis for PVP storage disease in bone can include such tumors as benign intraosseous notochordal neoplasms, chordoma, and metastatic signet-ring-cell adenocarcinoma, and endogenous storage disorders such as the mucopolysaccharidoses and mucolipidoses (149, 151, 154) .
The histochemical profile of PVP storage disease is characteristic. It includes reactivity with Best's' mucicarmine method, as well as the colloidal iron, methenamine silver, Congo red, Fontana-Masson, phosphotungstic acid-hematoxylin, and Victoria-blue stains. On the other hand, the periodic acid-Schiff, alcian-blue, and Giemsa techniques yield negative results (149, 152) . That constellation of findings distinguishes PVP storage disease from its morphological imitators. Moreover, unlike chordoma, other notochordal tumors, and carcinomas, this condition fails to label for pankeratin by immunohistochemistry (148) . The chemical identity of PVP can be established by mass spectroscopy done on excised tissue from the lesions (155) .
Depending on the quantity of PVP that has been infused or otherwise absorbed parenterally, the number of resulting lesions is greatly variable in affected organ sites. They may be only asymptomatic radiographic findings in bone, or, alternatively, they may produce lytic lesions that can be the foci for pathologic fractures (148) .
